← FDA Drug Approvals (Drugs@FDA)

LEVOCETIRIZINE DIHYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2024-05-06

Drug application

FDA Application #

ANDA204626

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOCETIRIZINE DIHYDROCHLORIDE

Generic name

Levocetirizine Dihydrochloride

Active ingredients

LEVOCETIRIZINE DIHYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

IPCA LABS LTD

First approval

2024-05-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown